CLINICAL_TRIALS
trial_result
· 2015-01-16
Clinical Trial Update: LUCAS (Lucentis Compared to Avastin Study) [Phase 4]
Summary
A Phase 4 trial comparing ranibizumab (Lucentis) to bevacizumab (Avastin) for exudative age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oslo University Hospital | Conditions: Exudative Age-related Macular Degeneration | Phase 4 | Status: COMPLETED